Cédric Geoffroy

Dr. Cédric Geoffroy

Department of Neuroscience & Experimental Therapeutics, College of Medicine, Texas A&M Health Science Center, Bryan, TX 77807, USA
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2020 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
PDF file
TSTheresa C. Sutherland
Theresa C. Sutherland
Cédric GeoffroyCédric Geoffroy
Cédric Geoffroy
In the aging western population, the average age of incidence for spinal cord injury (SCI) has increased, as has the length of survival of SCI patients. This places great importance on understanding SCI in middle-aged and aging patients. Axon regeneration after injury is an area of study that has received substantial attention and made important experimental progress, however, our understanding of how aging affects this process, and any therapeutic effort to modulate repair, is incomplete. The growth and regeneration of axons is mediated by both neuron intrinsic and extrinsic factors. In this review we explore some of the key extrinsic influences on axon regeneration in the literature, focusing on inflammation and astrogliosis, other cellular responses, components of the extracellular matrix, and myelin proteins. We will describe how each element supports the contention that axonal growth after injury in the central nervous system shows an age-dependent decline, and how this may affect outcomes after a SCI.

23 May 2018 in Science Translational Medicine
Verified
Journal Article
Closed access
GPGunnar H. D. Poplawski
Gunnar H. D. Poplawski
RLRichard Lie
Richard Lie
MHMatt Hunt
Matt Hunt
HKHiromi Kumamaru
Hiromi Kumamaru
RKRiki Kawaguchi
Riki Kawaguchi
MTMark H. Tuszynski
Mark H. Tuszynski
Axons emerging from rat neural stem cell implants in the injured spinal cord of rat recipients are stimulated to grow by myelin.

29 June 2021 in Cells
Verified
Journal Article
Open access
PDF file
Theresa SutherlandTheresa Sutherland
Theresa Sutherland
ASArthur Sefiani
Arthur Sefiani
DHDarijana Horvat
Darijana Horvat
THTaylor Huntington
Taylor Huntington
YLYuanjiu Lei
Yuanjiu Lei
Cédric GeoffroyCédric Geoffroy
Cédric Geoffroy
The age of incidence of spinal cord injury (SCI) and the average age of people living with SCI is continuously increasing. However, SCI is extensively modeled in young adult animals, hampering translation of research to clinical applications. While there has been significant progress in manipulating axon growth after injury, the impact of aging is still unknown. Mitochondria are essential to successful neurite and axon growth, while aging is associated with a decline in mitochondrial functions. Using isolation and culture of adult cortical neurons, we analyzed mitochondrial changes in 2-, 6-, 12- and 18-month-old mice. We observed reduced neurite growth in older neurons. Older neurons also showed dysfunctional respiration, reduced membrane potential, and altered mitochondrial membrane transport proteins; however, mitochondrial DNA (mtDNA) abundance and cellular ATP were increased. Taken together, these data suggest that dysfunctional mitochondria in older neurons may be associated with the age-dependent reduction in neurite growth. Both normal aging and traumatic injury are associated with mitochondrial dysfunction, posing a challenge for an aging SCI population as the two elements can combine to worsen injury outcomes. The results of this study highlight this as an area of great interest in CNS trauma.

18 June 2021 in Frontiers in Neuroscience
Verified
Journal Article
Open access
PDF file
ASArthur Sefiani
Arthur Sefiani
Cédric GeoffroyCédric Geoffroy
Cédric Geoffroy
Currently there are approximately 291,000 people suffering from a spinal cord injury (SCI) in the United States. SCI is associated with traumatic changes in mobility and neuralgia, as well as many other long-term chronic health complications, including metabolic disorders, diabetes mellitus, non-alcoholic steatohepatitis, osteoporosis, and elevated inflammatory markers. Due to medical advances, patients with SCI survive much longer than previously. This increase in life expectancy exposes them to novel neurological complications such as memory loss, cognitive decline, depression, and Alzheimer’s disease. In fact, these usually age-associated disorders are more prevalent in people living with SCI. A common factor of these disorders is the reduction in hippocampal neurogenesis. Inflammation, which is elevated after SCI, plays a major role in modulating hippocampal neurogenesis. While there is no clear consensus on the mechanism of the decline in hippocampal neurogenesis and cognition after SCI, we will examine in this review how SCI-induced inflammation could modulate hippocampal neurogenesis and provoke age-associated neurological disorders. Thereafter, we will discuss possible therapeutic options which may mitigate the influence of SCI associated complications on hippocampal neurogenesis.

30 September 2022 in Science Advances
Verified
Journal Article
Open access
JAJason K. Allen
Jason K. Allen
Theresa SutherlandTheresa Sutherland
Theresa Sutherland
APAustin R. Prater
Austin R. Prater
Cédric GeoffroyCédric Geoffroy
Cédric Geoffroy
JPJean-Philippe Pellois
Jean-Philippe Pellois
We report on the successful delivery of the Cre recombinase enzyme in the neural cells of mice in vivo by simple coinjection with peptides derived from HIV-TAT. Cre delivery activates the expression of a reporter gene in both neurons and astrocytes of the cortex without tissue damage and with a transduction efficiency that parallels or exceeds that of a commonly used adeno-associated virus. Our data indicate that the delivery peptides mediate efficient endosomal leakage and cytosolic escape in cells that have endocytosed Cre. The peptides, therefore, act in trans and do not require conjugation to the payload, greatly simplifying sample preparation. Moreover, the delivery peptides are exclusively composed of natural amino acids and are consequently readily degradable and processed by cells. We envision that this approach will be beneficial to applications that require the transient introduction of proteins into cells in vivo.

26 January 2022 in Biology
Verified
Journal Article
Open access
PDF file
Michelle HookMichelle Hook
Michelle Hook
AFAlyssa Falck
Alyssa Falck
RDRavali Dundumulla
Ravali Dundumulla
MTMabel Terminel
Mabel Terminel
RCRachel Cunningham
Rachel Cunningham
Cédric GeoffroyCédric Geoffroy
Cédric Geoffroy
After spinal cord injury (SCI), 80% of individuals are diagnosed with osteopenia or osteoporosis. The dramatic loss of bone after SCI increases the potential for fractures 100-fold, with post-fracture complications occurring in 54% of cases. With the age of new SCI injuries increasing, we hypothesized that a SCI-induced reduction in weight bearing could further exacerbate age-induced bone loss. To test this, young (2–3 months) and old (20–30 months) male and female mice were given a moderate spinal contusion injury (T9–T10), and recovery was assessed for 28 days (BMS, rearing counts, distance traveled). Tibial trabecular bone volume was measured after 28 days with ex vivo microCT. While BMS scores did not differ across groups, older subjects travelled less in the open field and there was a decrease in rearing with age and SCI. As expected, aging decreased trabecular bone volume and cortical thickness in both old male and female mice. SCI alone also reduced trabecular bone volume in young mice, but did not have an additional effect beyond the age-dependent decrease in trabecular and cortical bone volume seen in both sexes. Interestingly, both rearing and total activity correlated with decreased bone volume. These data underscore the importance of load and use on bone mass. While partial weight-bearing does not stabilize/reverse bone loss in humans, our data suggest that therapies that simulate complete loading may be effective after SCI.